CVE-2022-3901
Visioweb.js - Prototype Pollution can results in XSS
Prototype Pollution in Visioweb.js 1.10.6 allows attackers to execute XSS on the client system.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- Low
- Availability
- None
Exploit likelihood
What each source reports
CVE List Score used 7.2
Visioweb.js - Prototype Pollution can results in XSS
Prototype Pollution in Visioweb.js 1.10.6 allows attackers to execute XSS on the client system.
- Record
CVE-2022-3901- CVSS 3.1
- 7.2 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:N - Weakness
- CWE-1321
- Updated
- 2026-11-02
EUVDEUVD-2022-43237 7.2
Prototype Pollution in Visioweb.js 1.10.6 allows attackers to execute XSS on the client system.
- Record
EUVD-2022-43237- CVSS 3.1
- 7.2 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-h2jj-59xj-6r28 6.1
Prototype Pollution in Visioweb.js 1.10.6 allows attackers to execute XSS on the client system.
Prototype Pollution in Visioweb.js 1.10.6 allows attackers to execute XSS on the client system.
- Record
GHSA-h2jj-59xj-6r28- CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-1321
- Updated
- 2026-11-02
NVD 7.2
Prototype Pollution in Visioweb.js 1.10.6 allows attackers to execute XSS on the client system.
- Record
CVE-2022-3901- CVSS 3.1
- 7.2 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:L/I:L/A:N - CVSS 3.1
- 6.1 Medium
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N - Weakness
- CWE-1321
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-3901 is a high vulnerability (CVSS 7.2) in Visio Globe Visioweb, published February 20, 2023. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.40%, the 34th percentile. No source names a fixed version.